Brief Title
A NEW SCORING SYSTEM FOR PREDICTION OF PDA
Official Title
Can a New Scoring System Predict Hemodynamically Significant PDA Diagnosis and Treatment Requirement for Extremely Preterm Newborns Earlier
Brief Summary
Patent ductus arteriosus (PDA) is an important morbidity of that the diagnosis and treatment is controversy in premature infants. A number of scoring systems have been developed, including the findings of echocardiography on the diagnosis and treatment of PDA. This study aimed to develop a new clinical scoring system that will enable the rapid, standard and noninvasive evaluation of hemodynamically significant PDA earlier, without relying on echocardiographic findings in premature babies with extremely low birth weight, and to determine the role of this scoring system in early diagnosis and treatment.
Detailed Description
This study aimed to develop a new clinical scoring system that will enable the rapid, standard and noninvasive evaluation of hemodynamically significant PDA earlier, without relying on echocardiographic findings in premature babies with extremely low birth weight, and to determine the role of this scoring system in early diagnosis and treatment.
Study Type
Observational
Primary Outcome
Number of Participants with Patent Ductus Arteriosus
Condition
Patent Ductus Arteriosus
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
100
Start Date
January 15, 2019
Completion Date
February 15, 2021
Primary Completion Date
December 15, 2020
Eligibility Criteria
Inclusion Criteria: - informed consent obtained from parents - extremely preterm infants - infants born before 28 gestational week Exclusion Criteria: - lack of informed consent - chromosomal abnormality - cardiovascular abnormality
Gender
All
Ages
N/A - 15 Days
Accepts Healthy Volunteers
No
Contacts
, 05337180683, [email protected]
Location Countries
Turkey
Location Countries
Turkey
Administrative Informations
NCT ID
NCT04270240
Organization ID
MAEEAH6725
Responsible Party
Principal Investigator
Study Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Study Sponsor
, ,
Verification Date
May 2020